"Metabolic network analysis predicts efficacy of FDA-approved drugs ..."

Arvind K. Chavali et al. (2012)

> Home

Details and statistics

DOI: 10.1186/1752-0509-6-27

access: open

type: Journal Article

metadata version: 2020-05-05

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/bmcsb/ChavaliBTJPP12
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcsb/ChavaliBTJPP12
Arvind K. Chavali, Anna S. Blazier, Jose L. Tlaxca, Paul A. Jensen, Richard D. Pearson, Jason A. Papin:
Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease. BMC Syst. Biol. 6: 27 (2012)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.